Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baxter International Inc. stock logo
BAX
Baxter International
$30.09
+1.8%
$30.34
$26.25
$40.49
$15.44B0.634.45 million shs3.13 million shs
Hologic, Inc. stock logo
HOLX
Hologic
$63.04
+1.7%
$58.16
$51.90
$84.67
$14.05B0.542.27 million shs3.06 million shs
Integer Holdings Co. stock logo
ITGR
Integer
$119.97
+1.9%
$118.63
$104.93
$146.36
$4.19B1.03373,172 shs414,820 shs
Masimo Co. stock logo
MASI
Masimo
$163.83
-0.7%
$157.01
$101.61
$194.88
$8.88B1.23645,601 shs531,719 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baxter International Inc. stock logo
BAX
Baxter International
+1.87%-2.55%-1.95%-14.52%-11.70%
Hologic, Inc. stock logo
HOLX
Hologic
+1.66%+1.40%+16.40%+1.55%-15.42%
Integer Holdings Co. stock logo
ITGR
Integer
+1.94%-1.37%-4.51%-2.36%-1.06%
Masimo Co. stock logo
MASI
Masimo
-0.73%+4.18%-1.56%-12.01%+27.74%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Baxter International Inc. stock logo
BAX
Baxter International
4.488 of 5 stars
2.25.01.74.01.51.72.5
Hologic, Inc. stock logo
HOLX
Hologic
4.6888 of 5 stars
3.23.00.04.32.13.32.5
Integer Holdings Co. stock logo
ITGR
Integer
3.0928 of 5 stars
3.53.00.00.02.12.51.3
Masimo Co. stock logo
MASI
Masimo
4.2088 of 5 stars
3.41.00.04.23.02.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Baxter International Inc. stock logo
BAX
Baxter International
2.44
Hold$37.2523.78% Upside
Hologic, Inc. stock logo
HOLX
Hologic
2.41
Hold$77.4222.81% Upside
Integer Holdings Co. stock logo
ITGR
Integer
3.00
Buy$145.0020.86% Upside
Masimo Co. stock logo
MASI
Masimo
2.83
Moderate Buy$191.6016.95% Upside

Current Analyst Ratings Breakdown

Latest ITGR, BAX, HOLX, and MASI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/27/2025
Hologic, Inc. stock logo
HOLX
Hologic
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
5/22/2025
Integer Holdings Co. stock logo
ITGR
Integer
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy$133.00 ➝ $140.00
5/13/2025
Hologic, Inc. stock logo
HOLX
Hologic
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$77.00 ➝ $70.00
5/7/2025
Masimo Co. stock logo
MASI
Masimo
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$193.00
5/7/2025
Masimo Co. stock logo
MASI
Masimo
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00 ➝ $200.00
5/7/2025
Masimo Co. stock logo
MASI
Masimo
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$204.00 ➝ $185.00
5/7/2025
Masimo Co. stock logo
MASI
Masimo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$205.00 ➝ $190.00
5/5/2025
Baxter International Inc. stock logo
BAX
Baxter International
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$30.00 ➝ $28.00
5/5/2025
Hologic, Inc. stock logo
HOLX
Hologic
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$77.00 ➝ $65.00
5/2/2025
Baxter International Inc. stock logo
BAX
Baxter International
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$36.00 ➝ $33.00
5/2/2025
Hologic, Inc. stock logo
HOLX
Hologic
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$75.00 ➝ $70.00
(Data available from 6/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Baxter International Inc. stock logo
BAX
Baxter International
$10.77B1.43$4.67 per share6.45$16.69 per share1.80
Hologic, Inc. stock logo
HOLX
Hologic
$4.03B3.49$5.39 per share11.69$21.27 per share2.96
Integer Holdings Co. stock logo
ITGR
Integer
$1.75B2.40$7.90 per share15.18$48.27 per share2.49
Masimo Co. stock logo
MASI
Masimo
$2.13B4.18$5.33 per share30.74$25.79 per share6.35
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Baxter International Inc. stock logo
BAX
Baxter International
-$649M-$1.10N/A11.020.93-5.05%16.67%4.93%8/5/2025 (Estimated)
Hologic, Inc. stock logo
HOLX
Hologic
$789.50M$2.3719.8913.652.1418.42%19.72%10.94%7/28/2025 (Estimated)
Integer Holdings Co. stock logo
ITGR
Integer
$90.65M$2.1135.7118.041.726.92%11.65%5.89%7/24/2025 (Estimated)
Masimo Co. stock logo
MASI
Masimo
$81.50M-$9.17112.9935.38N/A3.85%14.98%6.95%8/5/2025 (Estimated)

Latest ITGR, BAX, HOLX, and MASI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2025Q1 2025
Masimo Co. stock logo
MASI
Masimo
$1.24$1.36+$0.12-$3.12$367.79 million$372.00 million
5/1/2025Q1 2025
Baxter International Inc. stock logo
BAX
Baxter International
$0.48$0.62+$0.14$0.25$2.59 billion$2.63 billion
5/1/2025Q2 2025
Hologic, Inc. stock logo
HOLX
Hologic
$1.02$1.03+$0.01-$0.08$1.00 billion$1.01 billion
4/24/2025Q1 2025
Integer Holdings Co. stock logo
ITGR
Integer
$1.27$1.31+$0.04-$0.66$428.51 million$437.39 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Baxter International Inc. stock logo
BAX
Baxter International
$0.682.26%-1.40%N/A N/A
Hologic, Inc. stock logo
HOLX
Hologic
N/AN/AN/AN/AN/A
Integer Holdings Co. stock logo
ITGR
Integer
N/AN/AN/AN/AN/A
Masimo Co. stock logo
MASI
Masimo
N/AN/AN/AN/AN/A

Latest ITGR, BAX, HOLX, and MASI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/6/2025
Baxter International Inc. stock logo
BAX
Baxter International
quarterly$0.172.27%5/30/20255/30/20257/1/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Baxter International Inc. stock logo
BAX
Baxter International
1.31
1.43
1.09
Hologic, Inc. stock logo
HOLX
Hologic
0.52
3.49
2.78
Integer Holdings Co. stock logo
ITGR
Integer
0.62
2.95
2.09
Masimo Co. stock logo
MASI
Masimo
0.50
2.01
1.11

Institutional Ownership

CompanyInstitutional Ownership
Baxter International Inc. stock logo
BAX
Baxter International
90.19%
Hologic, Inc. stock logo
HOLX
Hologic
94.73%
Integer Holdings Co. stock logo
ITGR
Integer
99.29%
Masimo Co. stock logo
MASI
Masimo
85.96%

Insider Ownership

CompanyInsider Ownership
Baxter International Inc. stock logo
BAX
Baxter International
0.21%
Hologic, Inc. stock logo
HOLX
Hologic
1.88%
Integer Holdings Co. stock logo
ITGR
Integer
2.16%
Masimo Co. stock logo
MASI
Masimo
9.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Baxter International Inc. stock logo
BAX
Baxter International
60,000513.18 million509.47 millionOptionable
Hologic, Inc. stock logo
HOLX
Hologic
6,940222.85 million220.17 millionOptionable
Integer Holdings Co. stock logo
ITGR
Integer
10,00034.89 million32.87 millionOptionable
Masimo Co. stock logo
MASI
Masimo
6,20054.22 million48.35 millionOptionable

Recent News About These Companies

Brokerages Set Masimo Co. (NASDAQ:MASI) Target Price at $191.60
Masimo (NASDAQ:MASI) Cut to Hold at Wall Street Zen
Zacks Research Has Bearish Forecast for Masimo Q2 Earnings
Zacks Research Estimates Masimo's Q1 Earnings (NASDAQ:MASI)
Is the Market Bullish or Bearish on Masimo?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Baxter International stock logo

Baxter International NYSE:BAX

$30.09 +0.54 (+1.84%)
Closing price 06/3/2025 03:59 PM Eastern
Extended Trading
$30.02 -0.07 (-0.25%)
As of 08:55 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Hologic stock logo

Hologic NASDAQ:HOLX

$63.04 +1.03 (+1.66%)
Closing price 06/3/2025 04:00 PM Eastern
Extended Trading
$63.10 +0.06 (+0.10%)
As of 08:38 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Integer stock logo

Integer NYSE:ITGR

$119.97 +2.28 (+1.94%)
Closing price 06/3/2025 03:59 PM Eastern
Extended Trading
$119.90 -0.07 (-0.06%)
As of 08:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Masimo stock logo

Masimo NASDAQ:MASI

$163.83 -1.20 (-0.73%)
Closing price 06/3/2025 04:00 PM Eastern
Extended Trading
$162.63 -1.20 (-0.73%)
As of 08:45 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.